Attached files
| file | filename |
|---|---|
| 10-K - 10-K - Medite Cancer Diagnostics, Inc. | v407237_10k.htm |
| EX-32.1 - EXHIBIT 32.1 - Medite Cancer Diagnostics, Inc. | v407237_ex32-1.htm |
| EX-31.1 - EXHIBIT 31.1 - Medite Cancer Diagnostics, Inc. | v407237_ex31-1.htm |
| EX-31.2 - EXHIBIT 31.2 - Medite Cancer Diagnostics, Inc. | v407237_ex31-2.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report (the “report”) of MEDITE Cancer Diagnostics, Inc. (the “Company”) on Form 10-K for the year ended December 31, 2013, I, Robert F. McCullough, Jr., the Chief Financial Officer of the Company, do hereby certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that to the best of my knowledge:
(1) the report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) the information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Date: May 08, 2015 | /s/ Robert McCullough Jr. |
| Robert McCullough Jr. | |
| Chief Financial Officer |